Obesity and Type 2 Diabetes: Two Diseases with a Need for Combined Treatment Strategies - EASO Can Lead the Way
Open accessThe DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Abstract
Obesity is a chronic metabolic disease affecting adults and children worldwide. It has become one of the leading causes of death, as obesity is known to be the main risk factor for a number of non-communicable diseases, in particular type 2 diabetes. This close relationship led to the connotation ‘diabesity', highlighting the fact that the majority of individuals with diabetes are overweight or obese. Until today the BMI is still used to classify overweight and obesity. Since reduced muscle mass is highly prevalent throughout the BMI range, the measurement of body composition is strongly recommended. Moreover, it is essential for monitoring the course of weight reduction, which is part of every effective anti-obesity treatment. Weight reduction can be achieved via different weight loss strategies, including lifestyle intervention (diet and exercise), pharmacotherapy, or bariatric surgery. However, not all of these strategies are suitable for all patients, and any further needs should be considered. Besides, attention should also be drawn to concomitant therapies. These therapies may promote additional weight gain and further trigger the deterioration of blood glucose control. Thus, therapeutic strategies are warranted, which can be easily used for the management of obese patients with type 2 diabetes to achieve their glycemic and weight loss goals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Obesity and T2D share key pathophysiological mechanisms and are both associated with increased risk for (i) metabolic complications [such as hypertension, dyslipidemia, obstructive sleep apnea (OSA) and metabolic-dysfunction associated steatotic liver disease (MASLD)] and (ii) cardiovascular disease [2,4].”
In the citing paper
“Obesity and T2D share key pathophysiological mechanisms and are both associated with increased risk for (i) metabolic complications [such as hypertension, dyslipidemia, obstructive sleep apnea (OSA) and metabolic-dysfunction associated steatotic liver disease (MASLD)] and (ii) cardiovascular disease [2,4].”
In the citing paper
“Obesity is the strongest risk factor for T2D and the obesity epidemic is heavily contributed to the rise of T2D prevalence, especially the increased rates of young-onset T2D [2].”
In the citing paper
“Obesity is the strongest risk factor for T2D and the obesity epidemic is heavily contributed to the rise of T2D prevalence, especially the increased rates of young-onset T2D [2].”
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15268-3 · Cited by 12,717
Prospective Studies Collaboration (2009) · The Lancet · doi:10.1016/s0140-6736(09)60318-4 · Cited by 4,807
Finucane, M. M., Stevens, G. A., Cowan, M. J., Danaei, G., Lin, J. K., Paciorek, C. J., Singh, G. M., Gutierrez, H. R., Lu, Y., Bahalim, A. N., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62037-5 · Cited by 4,050
European Guidelines for Obesity Management in Adults
Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., & Toplak, H. (2015) · Obesity Facts · doi:10.1159/000442721 · Cited by 3,432
Self-citationGlobal burden of obesity in 2005 and projections to 2030
Kelly, T., Yang, W., Chen, C.-S., Reynolds, K., & He, J. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.102 · Cited by 3,319
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
Schauer, P. R., Bhatt, D. L., Kirwan, J. P., Wolski, K., Aminian, A., Brethauer, S. A., Navaneethan, S. D., Singh, R. P., Pothier, C. E., Nissen, S. E., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1600869 · Cited by 2,934
Obesity and Diabetes in the Developing World — A Growing Challenge
Hossain, P., Kawar, B., & El Nahas, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmp068177 · Cited by 2,200
Weight Loss with a Low-Carbohydrate, Mediterranean, or Low-Fat Diet
Shai, I., Schwarzfuchs, D., Henkin, Y., Shahar, D. R., Witkow, S., Greenberg, I., Golan, R., Fraser, D., Bolotin, A., Vardi, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708681 · Cited by 2,143
Fuller, N. R., Colagiuri, S., Schofield, D., Olson, A. D., Shrestha, R., Holzapfel, C., Wolfenstetter, S. B., Holle, R., Ahern, A. L., Hauner, H., et al. (2013) · International Journal of Obesity · doi:10.1038/ijo.2012.139 · Cited by 2,117
Cited by
Items 201–300 of 430
Galstyan, G. R., Valeeva, F. V., Игоревна, М. С., Surkova, E. V., Савельева, Л. В., Rudina, L. M., Ramanathan, K., Sokareva, E., Bondareva, K. I., & Shestakova, M. V. (2021) · Obesity Science & Practice · doi:10.1002/osp4.502 · Cited by 6
“Obesity is an established risk factor for several noncommunicable diseases such as CV disease, T2DM, hypertension and coronary heart disease, and even certain cancers.(33) It is the basis for the development of insulin resistance and results in carbohydrate metabolism compensation, which is associated with CV risk fac…”
BackgroundAmirbeigi, A., Abbaslou, F., Talebpour, M., Soroush, A., Elyasinia, F., Mahmoudabadi, H. Z., & Najjari, K. (2022) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2022.104102 · Cited by 8
Pikó, P., Werissa, N. A., & Ádány, R. (2022) · Biomedicines · doi:10.3390/biomedicines10071703 · Cited by 7
“The development of IR is strongly influenced by environmental/lifestyle factors [16–18] such as physical (in)activity [19–22], age [23,24], obesity [25,26], smoking [27,28], and lowfiber diet [29], and it is generally accepted that individual risk is also strongly influenced by inheritable genetic factors [30,31], whi…”
BackgroundShams‐White, M., Tjaden, A. H., Edelstein, S. L., Bassiouni, S. S., Kahle, L., Kim, C., Pi-Sunyer, X., Temple, K. A., Venditti, E. M., Reedy, J., et al. (2022) · BMC Nutrition · doi:10.1186/s40795-022-00596-7 · Cited by 9
“This is expected given that the DPP study enrolled participants with overweight and obesity and there is strong evidence that weight loss is a major contributor to reduced diabetes incidence [18, 36].”
BackgroundAoe, S., Kawano, T., Naito, J., Nishida, N., & Takahashi, M. (2022) · Food Science & Nutrition · doi:10.1002/fsn3.3130 · Cited by 5
“Obesity is recognized as a major risk factor for morbidity and mortality, particularly lifestyle- related disorders such as type 2 diabetes, hypertension, and dyslipidemia (Klop et al., 2013; Leitner et al., 2017; Natsis et al., 2020).”
BackgroundKhater, S. I., Shalabi, M., Alammash, B. B., Alrais, A. I., Al-Ahmadi, D. S., Alqahtani, L. S., Khameis, T., Abdelaziz, S., Elkelish, A., & El-Dawy, K. H. (2023) · Journal of Advanced Veterinary and Animal Research · doi:10.5455/javar.2023.j684 · Cited by 7
Ruangchaisiwawet, A., Bankhum, N., Tanasombatkul, K., Phinyo, P., & Yingchankul, N. (2023) · PLoS ONE · doi:10.1371/journal.pone.0294810 · Cited by 10
Pilates for people with type 2 diabetes: A systematic review
González-Devesa, D., Rodríguez, A. O., Blanco-Martínez, N., & Ayán, C. (2023) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2023.102922 · Cited by 6
Memelink, R. G., Hijlkema, A., Valentin, B., Streppel, M. T., Pasman, W. J., Wopereis, S., den Bosch, J. D. V., Tieland, M., Schoufour, J. D., Bautmans, I., et al. (2024) · Lifestyle Medicine · doi:10.1002/lim2.103 · Cited by 8
Effects of Milkfat on the Gut Microbiome of Patients After Bariatric Surgery, a Pilot Study
O’Neill, L., Pandya, V., Grigoryan, Z., Patel, R. A., DeSipio, J., Judge, T. A., & Phadtare, S. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05805-z · Cited by 7
Corken, A. L., & Thakali, K. M. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2021.798987 · Cited by 6
Ziarniak, K., Yang, T., Boycott, C., Beetch, M., Sassek, M., Grzęda, E., Ma, Y., Sliwowska, J. H., & Stefañska, B. (2022) · Epigenetics · doi:10.1080/15592294.2022.2119120 · Cited by 7
“As being overweight or obese are the leading risk factors for the development of DM2 [28], using publicly available data in the Gene Expression Omnibus (GEO), we have analysed expression and DNA methylation of KISS1 and KISS1R in peripheral tissues in diabetic patients and/or obese individuals.”
MethodPrevalence of diabesity in Spain: it depends on how obesity is defined
Gómez‐Ambrosi, J., & Catalán, V. (2022) · Anales del Sistema Sanitario de Navarra · doi:10.23938/assn.0993 · Cited by 12
Noncanonical Regulation of cAMP‐Dependent Insulin Secretion and Its Implications in Type 2 Diabetes
Ramanadham, S., TURK, J. W., & Bhatnagar, S. (2023) · Comprehensive physiology · doi:10.1002/cphy.c220031 · Cited by 13
Candidate Gene Expression in Adult Zebrafish Models of Type 2 Diabetes Mellitus
Shezi, M. N., Snyman, C., & Niesler, C. U. (2024) · Zebrafish · doi:10.1089/zeb.2024.0154 · Cited by 5
Merwass, N. A., Alkhader, Y. K., Alharthi, S. A., Fardan, R. M. A., Alqahtani, A., Mahnashi, F. A., Salam, N. M., Najim, M. M. A., Alenezi, A., & Binobaid, A. O. (2024) · Cureus · doi:10.7759/cureus.63952 · Cited by 18
“Because of their close relationship, the term "diabesity" has emerged to refer to the condition in which most people with diabetes are overweight or obese [20].”
BackgroundCurreli, M., Recalchi, S., Masi, D., Rossetti, R., Ernesti, I., Camaiani, E., Basciani, S., Gangitano, E., Watanabe, M., Mariani, S., et al. (2025) · Nutrients · doi:10.3390/nu17020312 · Cited by 5
“Furthermore, obesity has been shown to impair immune function, leading to a reduced responsiveness to vaccines [1,2].”
Mapping obesity and diabetes’ representation on Twitter: the case of Italy
Lenzi, F. R., & Iazzetta, F. (2023) · Frontiers in Sociology · doi:10.3389/fsoc.2023.1155849 · Cited by 6
“According to the World Health Organization, global obesity has nearly tripled since 1975 (Vespasiani et al., 2005; Leitner et al., 2017; Lenzi and Filardi, 2022; Veit et al., 2022).”
BackgroundVincenzo, A. D., Granzotto, M., Trevellin, E., Purificati, C., Vecchiato, M., D, M. F. M., Pesavento, M., Vettor, R., & Rossato, M. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02412-4 · Cited by 5
“Obesity is recognized as the main predisposing factor for CVD in Western Countries [2–4], and considering its epidemic diffusion, with 1 adult in 2 in the United States predicted to suffer from obesity in 2030 [5], the treatment of obesity will represent in the future the most successful…”
InfluentialFrequently used medicinal herbs and spices in weight management: a review
Boaz, M., Shriqui, V. K., Dagan, S. S., Salem, H., & Navarro, D. A. (2020) · Functional Foods in Health and Disease · doi:10.31989/ffhd.v10i7.719 · Cited by 10
“Endocrinol Metab 2018;314(4):E334-E52.”
BackgroundAlimanesh, Z., Alimanesh, Z., Davari, F., Shadmehri, S., Ahmadi, M., Hosseini, S. A., Dolati, S., & Far, A. H. (2020) · Molecular & cellular biomechanics · doi:10.32604/mcb.2020.011532 · Cited by 5
“Obesity is known to be an important factor in insulin resistance and DM [3].”
BackgroundEvaluating the need for dermatological care in a postsurgical bariatric sample
Butt, M., Khesroh, E., Simmers, J., Rogers, A. M., Helm, M. F., & Rigby, A. (2021) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2021.03.021 · Cited by 5
Pustovalov, A. S., Ratushna, K. V., Matviienko, M. G., Grodzyuk, G. Y., Andryushina, N. S., & Dzerzhynsky, M. (2022) · Fìzìologìčnij žurnal · doi:10.15407/fz68.02.074 · Cited by 5
Investigating the Expression and Function of the Glucose Transporter GLUT6 in Obesity
Chen, S.-Y., Olzomer, E. M., Beretta, M., Cantley, J., Nunemaker, C. S., Hoehn, K. L., & Byrne, F. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179798 · Cited by 9
“Obesity is closely related to type 2 diabetes, and the majority of patients with type 2 diabetes are overweight or obese [2].”
BackgroundAdipositas und Typ-2-Diabetes (Update 2023)
Clodi, M., Toplak, H., Resl, M., Brix, J. M., Leitner, D. R., Harreiter, J., Hoppichler, F., Wascher, T. C., Schindler, K., & Ludvik, B. H. (2023) · Wiener klinische Wochenschrift · doi:10.1007/s00508-023-02184-6 · Cited by 7
Self-citationReducing diabetes risk at an early age
Hsia, D. S., & Heymsfield, S. B. (2018) · Nature Medicine · doi:10.1038/s41591-018-0067-x · Cited by 5
Zhang, X., Gao, S., Liu, M., Wei, N., Zhang, Q., Li, X., & Niu, X. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119313 · Cited by 5
Mao, X., Larsen, S. B., Zachariassen, L. F., Brunse, A., Adamberg, S., Castro-Mejía, J. L., Larsen, F., Adamberg, K., Nielsen, D. S., Hansen, A. K., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.20.532903 · Cited by 5
“It is also a risk factor for the later development of other metabolic comorbidities, such as type-2 diabetes and metabolic dysfunction-associated fatty liver disease (MAFLD) 2,3 .”
BackgroundIqbal, M. Z., & Alqahtani, S. S. (2025) · Scientific Reports · doi:10.1038/s41598-025-04439-w · Cited by 6
Zheng, L., Yang, Y., Dong, G., Qin, X., Li, W., Zhang, Y., Li, H., Zhang, S., He, P. C., Ye, Q., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70159 · Cited by 4
Ohira, M., Watanabe, Y., Yamaguchi, T., Onda, H., Yamaoka, S., Abe, K., Nakamura, S., Tanaka, S., Kawagoe, N., Nabekura, T., et al. (2021) · Obesity Facts · doi:10.1159/000519410 · Cited by 4
Akowuah, P. K., Lema, C., Rumbaut, R. E., & Burns, A. R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24020931 · Cited by 4
RNA therapeutics for metabolic disorders
Vu, T.-D., Lin, S., Wu, C., & Chu, D. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2023.12.014 · Cited by 5
Voros, C., Mpananis, K., Papapanagiotou, A., Pouliakis, A., Mavrogianni, D., Mavriki, K., Gkaniatsos, I., Karasmani, C., Prokopakis, I., Darlas, M., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13041146 · Cited by 5
Sihag, S., Mathur, R., Bissa, M. S., & Bhawani, J. (2024) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_62_24 · Cited by 4
Spanos, M., Gokulnath, P., Whittaker, O. R., Azzam, C., Chatterjee, E., Singh, A., Varrias, D., Kladas, M., Vulugundam, G., Raptis, D., et al. (2024) · Physiologia · doi:10.3390/physiologia4040021 · Cited by 5
“Obesity has a well-established association with T2D acting as a risk factor and a comorbidity [75].”
Analyses of mitochondrial metabolism in diseases: a review on 13 C magnetic resonance tracers
Sharma, G., Duarte, S., Shen, Q., & Khemtong, C. (2024) · RSC Advances · doi:10.1039/d4ra03605k · Cited by 6
Utilization of Preventive Care Services at a University Hospital in Saudi Arabia
Alghamdi, M., Al-Raddadi, R. M., Althomali, O. W., & Bazaid, A. S. (2021) · Health Scope · doi:10.5812/jhealthscope.119996 · Cited by 4
Ahmed, A. A., Musa, H. H., Essa, M. E. A., Mollica, A., Zengin, G., Ahmad, H., & Adam, S. Y. (2022) · Carbohydrate Polymer Technologies and Applications · doi:10.1016/j.carpta.2022.100231 · Cited by 8
Yoo, T. K., Han, K., Kim, Y., Nam, G. E., Park, S. H., Rhee, E., & Lee, W. (2023) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2022.0242 · Cited by 6
“This strong association between DM and obesity has led to the connotation of the term “diabesity” [8].”
BackgroundTransplantation of adipose derived stem cells in diabetes mellitus; limitations and achievements
Tajali, R., Eidi, A., Tafti, H. A., Pazouki, A., Kamarul, T., & Sharifi, A. M. (2023) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-023-01280-8 · Cited by 7
Oh, K. E., Kim, Y. J., Oh, Y. R., Kang, E., Nam, H., Rhie, Y., & Lee, K. (2023) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2244214.107 · Cited by 4
“13,14) Many obese adolescents stay obese into adulthood and obesity-related comorbidities begin as early as childhood, which increases morbidity and mortality due to cardiovascular, metabolic, or oncological illnesses.”
BackgroundSarkar, P., Chatterjee, D., & Bandyopadhyay, A. R. (2020) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-020-00861-0 · Cited by 4
Targeting Obesity in Cardiovascular Disease Management: Cardiac Adipose Tissue Is a Real Biomarker!
D’Elia, S., Luisi, E., Solimene, A., Serpico, C., Morello, M., Titolo, G., Caso, V. M., Loffredo, F. S., Golino, P., Cimmino, G., et al. (2025) · Targets · doi:10.3390/targets3020017 · Cited by 5
Kiyici, S. K., Demirci, İ., Sönmez, A., Haymana, C., Mert, M., Nuhoğlu, İ., Taşçı, İ., Salman, S., Satman, İ., Bayram, F., et al. (2025) · Obesity Facts · doi:10.1159/000547136 · Cited by 3
“GLP-1 RAs and SGLT-2 inhibitors are associated with clinically meaningful weight loss [27].”
Self-citationPokrovskaya, E. V., Shestakova, E. A., & Shestakova, M. V. (2023) · Diabetes Mellitus · doi:10.14341/dm13088 · Cited by 4
Murfet, G. O., Robertson, I. K., Luccisano, S. P., & Kilpatrick, M. (2024) · Clinical Obesity · doi:10.1111/cob.12715 · Cited by 5
Sinke, L., Beekman, M., Raz, Y., Gehrmann, T., Moustakas, I., Boulinguiez, A., Lakenberg, N., Suchiman, H. E. D., Bogaards, F. A., Bizzarri, D., et al. (2024) · Aging Cell · doi:10.1111/acel.14431 · Cited by 4
“Regular aerobic exercise alongside caloric restriction promotes weight loss, insulin sensitivity, and glucose control in both younger and older populations (Eriksson et al., 1999 ; Kraus et al., 2019; Leitner et al., 2017; Zhang et al., 2020 ).”
Nicolas, G. M., & Ma, S. (2025) · Food Wellness · doi:10.1016/j.foodw.2025.100003 · Cited by 8
Herrera-González, A., León, A., Rodríguez, F. M., Sepúlveda, E. M., Guilbert, L., Quiroz, O. R., Cevallos, L., & Zerrweck, C. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04920-7 · Cited by 4
“Obesity is one of the main risk factors for chronic degenerative diseases [1].”
BackgroundHaskins, I. N., Jackson, H. T., Sparks, A. D., Vaziri, K., Tanner, T. N., Kothari, V. M., McBride, C. L., & Farrell, T. M. (2022) · Obesity Surgery · doi:10.1007/s11695-022-06243-1 · Cited by 5
“” [3] Bariatric surgery, and specifically Roux-en-Y gastric bypass (RYGB), is now part of the treatment algorithm for obese patients with T2DM due to the cardiometabolic benefits afforded to these patients through bariatric surgery [4].”
BackgroundBaşalan, M., Takır, M., Torun, C., & Sermet, M. (2023) · Marmara medical journal · doi:10.5472/marumj.1381218 · Cited by 3
Mechanisms of spinophilin-dependent pancreas dysregulation in obesity
Stickel, K. C., Shah, N. R., Claeboe, E. T., Orr, K. S., Mosley, A. L., Doud, E. H., Belecky‐Adams, T. L., & Baucum, A. J. (2024) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00099.2023 · Cited by 3
Al-Qahtani, A. A. (2024) · Journal of General and Family Medicine · doi:10.1002/jgf2.659 · Cited by 11
“52 While a number of research studies including systematic reviews and meta-analyses were unable to confirm the impact of Chronic Care Model intervention on low-density lipoprotein cholesterol, 5,41,53 only study that reported significant decrease in low-density lipoprotein cholesterol…”
BackgroundShortcomings, limitations and gaps in physiological roles of extracellular vesicles in obesity
Valero, P., Silva, K., Valenzuela‐Hinrichsen, A., Vasquez, A. O., Espinoza, F., Lira, F., Cornejo, M., Fuentes, G. A., González, D. R., Moore‐Carrasco, R., et al. (2024) · The Journal of Physiology · doi:10.1113/jp286955 · Cited by 6
“The potential involvement of EVs in patients with obesity who develop T2DM, often referred to as patients having ‘diabesity’ (Leitner et al., 2017; Ng et al., 2021), is not well understood.”
Conte, C. (2021) · Springer eBooks · doi:10.1007/978-3-030-80267-7_7 · Cited by 5
Design of Whey-Protein Stabilized Curcumin Nanoemulsions for Metabolic Syndrome Management
Jiménez-Escobar, M. P., Bautista-Hernández, S., Meza, S. H., Jiménez‐Fernández, M., Rascón-Díaz, M. P., Flores‐Andrade, E., Sánchez-Medina, A., & Pascual-Pineda, L. A. (2025) · BioNanoScience · doi:10.1007/s12668-025-01927-1 · Cited by 2
Khan, K. A. K., Khalid, M., Parapur, S. T., Doni, M., & Husain, N. (2025) · Phytomedicine Plus · doi:10.1016/j.phyplu.2025.100847 · Cited by 3
Li, Y., Wang, F., Wang, K., Chen, G., Bai, L., Shi, J., & Yu, D. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108768 · Cited by 3
Tseyslyer, Y. V., Malyi, V., Saifullina, M., Tsyryuk, O., Shvets, Y. V., Penchuk, Y., Kovalchuk, I., Kovalchuk, O. I., Korotkyi, O., Bulda, V., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1699954 · Cited by 3
Ghafri, T. A., Harthi, T. A., Jufaili, F. A., Ghammari, A. A., Haddabi, N. A., Riyami, A. A. A., Balushi, S. A., Kindi, H. A., Araimi, S. A., Ambusaidi, S., et al. (2025) · Public Health · doi:10.1016/j.puhe.2025.106045 · Cited by 5
Jain, A., Kristensen, P. N., Wasehuus, R. S., Kruse, C., & Nørtoft, E. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70350 · Cited by 3
Zhu, D., Li, R., Sun, Y., Li, Y., Ruan, J., & Wang, J. (2026) · Industrial Crops and Products · doi:10.1016/j.indcrop.2025.122574 · Cited by 2
Li, X., Bai, L., Zhang, Y., Wang, Y., Shi, Y., & Liu, H. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119549 · Cited by 2
Integrated analysis of lncRNA and mRNA expression profiles in the submandibular glands of DIO mice
Liu, H., Liu, L., Zhang, Y., Cong, X., Wu, L., & Xiang, R. (2021) · Oral Diseases · doi:10.1111/odi.13952 · Cited by 2
Spices for Diabetes, Cancer and Obesity Treatment
Ahmad, U., Nazir, A., Ahmad, S., & Asghar, N. (2021) · Springer eBooks · doi:10.1007/978-3-030-72999-8_9 · Cited by 2
Epigenetics and precision medicine in diabetes and obesity prevention and management
Izquierdo, A. G., Lorenzo, P. M., & Crujeiras, A. B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823008-4.00012-3 · Cited by 2
The association of LEPR Q223R polymorphism with type 2 diabetes mellitus in Malaysia
Al-fahham, L. A. A., Jemon, K. B., Latif, N. A., Bakar, S. A., & Alwi, S. S. S. (2022) · Human Gene · doi:10.1016/j.humgen.2022.201044 · Cited by 2
Albogami, S. M., Hassan, A. M., Abdel‐Aziem, S. H., Alotaibi, S. S., Althobaiti, F., El‐Shehawi, A. M., Alnefaie, A., & Alhamed, R. A. (2022) · PeerJ · doi:10.7717/peerj.13990 · Cited by 4
Impact of Obesity on Outcomes Associated With Acute Alcoholic Pancreatitis
Pellegrini, J. R., Sodoma, A. M., Munshi, R., Russe-Russe, J. R., Arias, J., Farraj, K. L., Pellegrini, R. G., & Singh, J. (2024) · Cureus · doi:10.7759/cureus.51653 · Cited by 4
“A study by the Journal of the Endocrine Society found that morbidly obese patients (BMI≥ 40kg/m2) had increased odds of mortality, hypocalcemia, sepsis, and acute kidney injury [13].”
BackgroundRajab, E., Wasif, P., Doherty, S., Gaynor, D., Malik, H., Fredericks, S., Al-Qallaf, A., Almuqahwi, R., Alsharbati, W. E., & Rashid‐Doubell, F. (2024) · Digital Health · doi:10.1177/20552076241251997 · Cited by 4
Alrasheed, A. A., AbuDujain, N. M., Almohammedi, S. M., Alrayes, R., Alajlan, F., Abdulqader, O. M., Albarrak, M., Alharbi, K. H., Almigbal, T. H., & Batais, M. A. (2024) · Healthcare · doi:10.3390/healthcare12131281 · Cited by 2
“It [7,8].”
Park, Y. S., Ahn, K., Yun, K., Jeong, J.-U., Baek, K., Park, D. J., Han, K., & Ahn, Y. J. (2024) · International Journal of Obesity · doi:10.1038/s41366-024-01611-6 · Cited by 3
“Treating obesity and DM often involves a combination of lifestyle changes, medication, and, in some cases, insulin therapy [16].”
BackgroundJannas-Vela, S., Langer, H. T., Marambio, H., Baar, K., & Zbinden‐Foncea, H. (2020) · Physiological Reports · doi:10.14814/phy2.14429 · Cited by 3
“physiological conditions, of which type 2 diabetes is one of the most common (Eckel et al., 2011; Leitner et al., 2017).”
BackgroundJeevitha, D., Olickal, J. J., Ulaganeethi, R., Singh, A., Ramesh, R., & Chinnakali, P. (2020) · International Journal of Adolescent Medicine and Health · doi:10.1515/ijamh-2019-0148 · Cited by 4
Puspitasari, P., Rinata, E., Dijaya, R., Aprilia, S., Trikumalasari, D., Azzah, L. N., Fanani, Q., Mushlih, M., Aliviameita, A., & Delta, D. (2019) · Medical Laboratory Technology Journal · doi:10.31964/mltj.v0i0.229 · Cited by 2
“Obesity and type 2 diabetes: Two diseases with a need for combined treatment strategies - EASO can lead the way.”
BackgroundInfluentialLim, E.-M., Park, S.-H., & Yoon, J.-H. (2018) · Exercise Science · doi:10.15857/ksep.2018.27.4.303 · Cited by 2
Gearing up for the Future: Mitigating Dysregulated Inflammation in Aging and Facets of Obesity
Xu, W., & Larbi, A. (2020) · Immunometabolism · doi:10.20900/immunometab20210002 · Cited by 2
The influence of manual therapy on biometric parameters in patients with improper body weight.
Antoniak-Pietrynczak, K., Hansdorfer-Korzon, R., Wojtowicz, D., Koziński, M., & Zorena, K. (2021) · International Electronic Conference on Environmental Research and Public Health (ECERPH) · doi:10.3390/ecerph-3-09029 · Cited by 2
“Obesity is now recognized as a chronic or non-communicable disease [1-2].”
BackgroundMohammed, M., Ahmed, F., Othman, H. H., & Ahmad, S. (2021) · Journal of Sulaimani Medical College · doi:10.17656/jsmc.10294 · Cited by 3
Marine Derived Bioactives to Combat Obesity: Potential Mechanisms of Action
Phadtare, I., Vaidya, H. B., & Cheema, S. K. (2021) · Advances in biochemistry in health and disease · doi:10.1007/978-3-030-84763-0_20 · Cited by 2
Das, A. K., Kalra, S., Joshi, S., Mithal, A., M., P. K. K., Unnikrishnan, A., Thacker, H. P., Sethi, B. K., Chowdhury, S., Sugumaran, A., et al. (2023) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.404 · Cited by 3
Heald, A. H., Qin, R., Loureiro, C. M., Williams, R., Dopson, C. D., Gibson, M., Narayanan, R. P., Fachim, H., McCay, K. D., & Ollier, W. (2023) · Adipocyte · doi:10.1080/21623945.2023.2236757 · Cited by 2
“This is because increasing obesity can further complicate the maintenance of optimal blood glucose control [2,3] and also drive biological pathways of multi-morbidity [4].”
BackgroundThe Evolution of Type 2 Diabetes Mellitus and Insulin Resistance
(2023) · doi:10.31038/edmj.2023732 · Cited by 1
“Obesity has been reported to account for 80-85% of the risk of developing type 2 diabetes, while recent research suggests that obese people are up to 80 times more likely to develop type 2 diabetes than those with a BMI of less than 22 [44].”
BackgroundSánchez-Cordero, S., Vilallonga, R., Rangarajan, M., Luna, M. R. R., Beisani, M., & Armengol, M. (2020) · Bariatric Surgical Practice and Patient Care · doi:10.1089/bari.2020.0032 · Cited by 2
“4,5 In this population, coronavirus can cause more severe symptoms and complications.”
Identification of molecular markers for type 2 Diabetes mellitus in Sidoarjo, Indonesia
Mushlih, M., Sari, F. K., Amin, H. S., & Iknan, S. A. (2020) · Jurnal Teknologi Laboratorium · doi:10.29238/teknolabjournal.v9i2.235 · Cited by 2
Matta-Coelho, C., Agius, R., Crane, J. D., & McGowan, B. M. (2021) · British Journal of Diabetes · doi:10.15277/bjd.2021.281 · Cited by 2
“4); Diabetes duration: 6 years (4) OADs : Metformin 75 (63), SUs 22 (18.”
Molecular aspects of signalling in diabesity
Sobrevía, L., & Desoyé, G. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.04.003 · Cited by 2
Harder, L., de Andrade, T. K., Serra, F. B., Pinho, F. M., Pinzón, A., & Orengo, J. C. (2020) · Research Square · doi:10.21203/rs.3.rs-61621/v1 · Cited by 2
Voller, B., Woodward, R. M., Gu, Q., Murrin, O., Delgado, J., Violán, C., Khalid, S., Türkmen, D., Fox, C., Lamb, S. E., et al. (2025) · medRxiv · doi:10.1101/2025.10.03.25337275 · Cited by 2
Development of Stressor Scale for Obese People
Rehman, R., & Ijaz, T. (2021) · Pakistan Journal of Psychological Research · doi:10.33824/pjpr.2021.36.3.24 · Cited by 1
Epigenetic Modifications in Obesity and Type 2 Diabetes
Li, Y. (2022) · The Open Biochemistry Journal · doi:10.2174/1874091x-v16-e2206271 · Cited by 1
Dietary Management after Bariatric Surgery in Patients with Obesity and Diabetes
Heo, J. (2023) · Journal of Korean Diabetes · doi:10.4093/jkd.2023.24.2.95 · Cited by 1
Abichandani, V. K., & Kalhan, A. (2023) · Chronicle of Diabetes Research and Practice · doi:10.4103/cdrp.cdrp_cdrp_20_22 · Cited by 1
Raskar, V., Singh, S. K., Suri, S., Shankar, P., Sonawane, A. B., Hasnani, D., & Chavda, V. (2022) · International Journal of Diabetes and Technology · doi:10.4103/ijdt.ijdt_7_23 · Cited by 1
Dibal, N. I., Goni, Z. M., Attah, M. O. O., Imam, U. B., Abdullahi, M. A., Bashir, M., Adam, U., Aisami, F., Shuwa, M., Manye, S. J., et al. (2023) · Borneo Journal of Pharmacy · doi:10.33084/bjop.v6i3.5351 · Cited by 1
“Obesity is one of the common non-communicable diseases with an alarming global health concern 1 .”
BackgroundApplication of Biomarkers in Obese Infertile Women: A Genetic Tool for a Personalized Treatment
Voros, C., Bananis, K., Papapanagiotou, A., Pouliakis, A., Mavriki, K., Gkaniatsos, I., Daskalaki, M. A., Prokopakis, I., Τsimpoukelis, C., Koulakmanidis, A.-M., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13082261 · Cited by 2
Vázquez, L. A., Tofé, S., Bellido, D., Botella-Serrano, M., Soto-González, A., Mezquita‐Raya, P., Delgado, E., Fajardo, C., Morales, C., Causanilles, A., et al. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01587-6 · Cited by 2
“Overweight and obesity are two of the main modifiable T2DM‑related risk factors, strongly associated with insulin resistance, one of the key features in the pathogenesis of T2DM, and one of the barriers to achieving good glycemic control [14].”
BackgroundAssociation between sociodemographic variables, healthy habits and stress with diabesity
López‐González, Á. A., Rifá, E. M.-A., Oliveira, H. P., Sánchez, C. M., López, P. J. T., & Ramírez‐Manent, J. I. (2025) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2025.500754 · Cited by 2
Weight change and diabetes risk following breast cancer: a nationwide cohort study
Jung, W., Jung, J.-H., Cho, I. Y., Yu, J., Baek, J.-H., Han, K., Park, Y., & Shin, D. W. (2025) · Journal of Cancer Survivorship · doi:10.1007/s11764-025-01898-y · Cited by 1
“These findings align with biological mechanisms whereby obesity induces a proinflammatory state and insulin resistance, [29] further exacerbated by treatment-related metabolic alterations [30], as well as prior observational evidence [31].”
Metadata
- Authors
- Leitner, D. R., Frühbeck, G., Yumuk, V., Schindler, K., Micic, D., Woodward, E., & Toplak, H.
- Affiliations
- University of Graz (AT)
- Instituto de Salud Carlos III (ES)
- Istanbul University-Cerrahpaşa (TR)
- Medical University of Vienna (AT)
- European Association for the Study of Obesity (GB)
- Venue
- Obesity Facts
- Publisher
- S. Karger AG
- Published
- 2017
- Volume
- 10
- Issue
- 5
- Pages
- 483-492
- ISSN
- 1662-4025 (ISSN-L)
- 1662-4033
- PMC
- PMC5741209
- OpenAlex
- W2762120405
- Cited by
- 431
- References
- 76
- Citations by year
- 2026: 16 · 2025: 51 · 2024: 67 · 2023: 80 · 2022: 76 · 2021: 68 · 2020: 51 · 2019: 14 · 2018: 8
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- creativecommons.org/licenses/by-nc-nd/4.0/ (tdm)
- Locations
- Obesity Facts (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- obesity, type 2 diabetes, diabesity, body composition, weight loss, lifestyle intervention, pharmacotherapy, bariatric surgery, glycemic control
- MeSH terms
- Adult, Child, Combined Modality Therapy, Diabetes Mellitus, Type 2, Diet, Health Services Needs and Demand, Humans, Life Style, Obesity, Exercise, Comorbidity, Anti-Obesity Agents, Bariatric Surgery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.